These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3673468)
1. Use of tartaric acid resistance of beta-glucuronidase for the characterization of cancer cells in pleural effusions. Apibal S; Sestapruks P; Bunyaratvej A; Srivannaboon S; Charoenpan P Acta Cytol; 1987; 31(5):611-4. PubMed ID: 3673468 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions. Di Carlo A; Terracciano D; Mariano A; Macchia V Int J Oncol; 2005 May; 26(5):1363-8. PubMed ID: 15809729 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions. Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986 [TBL] [Abstract][Full Text] [Related]
4. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Davidson B; Konstantinovsky S; Kleinberg L; Nguyen MT; Bassarova A; Kvalheim G; Nesland JM; Reich R Gynecol Oncol; 2006 Sep; 102(3):453-61. PubMed ID: 16494928 [TBL] [Abstract][Full Text] [Related]
5. Distribution pattern of concanavalin A on carcinoma cells, histiocytes and mesothelial cells from effusions. Lubínski J Acta Cytol; 1987; 31(2):99-103. PubMed ID: 3103357 [TBL] [Abstract][Full Text] [Related]
6. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Ciampa A; Fanger G; Khan A; Rock KL; Xu B Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of monitoring beta-glucuronidase in pleural effusions. Cobben NA; Drent M; Van Dieijen-Visser MP; Mulder PG; Wouters EF; Henderson RF Clin Biochem; 1999 Nov; 32(8):653-8. PubMed ID: 10638949 [TBL] [Abstract][Full Text] [Related]
8. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters. Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270 [TBL] [Abstract][Full Text] [Related]
9. Enzyme cytochemistry of benign and malignant cells in pleural and peritoneal fluid. Blonk DI; Schaberg A; Willighagen RG Acta Cytol; 1967; 11(6):460-5. PubMed ID: 4169938 [No Abstract] [Full Text] [Related]
10. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750 [TBL] [Abstract][Full Text] [Related]
11. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleural effusions. Vanisree AJ; Shyamaladevi CS Indian J Cancer; 1999; 36(2-4):127-34. PubMed ID: 10921216 [TBL] [Abstract][Full Text] [Related]
12. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors. Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002 [TBL] [Abstract][Full Text] [Related]
13. [Pleural effusions and cytology. A follow-up study of 338 patients with pleural effusion]. Kunnas RJ; Laitio MT; Tyrkkö JE; Järvi OH Duodecim; 1971; 87(9):720-32. PubMed ID: 5577126 [No Abstract] [Full Text] [Related]
14. Cathepsin-D activity in plasma and pleural effusions in patients with bronchogenic carcinoma and nonmalignant disease. Starling JR; Murray GF; Wilcox BR; Johnson G Surg Forum; 1975; 26():180-1. PubMed ID: 766253 [No Abstract] [Full Text] [Related]
15. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [TBL] [Abstract][Full Text] [Related]
16. Distinction of mononuclear macrophages from mesothelial cells in pleural and peritoneal effusions. Bakalos D; Constantakis N; Tsicricas T Acta Cytol; 1974; 18(1):20-2. PubMed ID: 4129932 [No Abstract] [Full Text] [Related]
17. Immunocytochemical detection of ovarian carcinoma cells in serous effusions. Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129 [TBL] [Abstract][Full Text] [Related]
18. Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions. Di Carlo A; Mariano A; Terracciano D; Mazzarella C; Galzerano S; Cicalese M; Cecere C; Macchia V Oncol Rep; 2007 Aug; 18(2):425-31. PubMed ID: 17611666 [TBL] [Abstract][Full Text] [Related]
19. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350 [TBL] [Abstract][Full Text] [Related]
20. [Phagocytosis of blood cells in pleural effusions]. Baumann UA; Löchner C; Bürgi W Schweiz Med Wochenschr; 1986 Sep; 116(37):1280-3. PubMed ID: 3764399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]